Adult Obesity and Health-Related Quality of Life, Patient Activation, Work Productivity, and Weight Loss Behaviors in the United States.
HRQoL
activation
behaviors
health-related quality of life
obesity
productivity
Journal
Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585
Informations de publication
Date de publication:
2020
2020
Historique:
received:
10
01
2020
accepted:
23
05
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
2
7
2020
Statut:
epublish
Résumé
While it is generally believed that people living with more severe obesity experience greater negative impacts on health-related quality of life (HRQoL), their experience may be impacted by other factors such as age, gender, and type 2 diabetes mellitus (T2DM). The 36-Item Short Form Health Survey physical component score and mental component score, Work Productivity and Activity Impairment, and Patient Activation Measure Overall, as BMI increased people had greater negative effects on HRQoL, felt less involved with and in control of their healthcare, and had greater work productivity and activity impairments. The largest declines were generally observed between class 2 and 3 obesity categories. Young adults with obesity were more likely to feel less engaged with their health care than middle-aged/older adults with obesity. The effects of obesity on HRQoL and patient activation were generally consistent by gender. People with T2DM and obesity tended to have greater declines in physical functioning and more work and activity impairments than people with obesity without T2DM. The proportion of people trying to lose weight increased with increasing BMI category, and people with T2DM were less likely to exercise and more likely to diet than those without T2DM. Increasing levels of obesity tended to have a greater negative impact on HRQoL, patient activation, work productivity, and weight loss behaviors, but some differences in effects by age, gender, and T2DM status were observed.
Identifiants
pubmed: 32606863
doi: 10.2147/DMSO.S245486
pii: 245486
pmc: PMC7306452
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2049-2055Informations de copyright
© 2020 Rozjabek et al.
Déclaration de conflit d'intérêts
H.R. and J.F. are full-time employees of Janssen Global Services, LLC. A.L. and N.S. are full-time employees of Kantar. The authors report no other conflicts of interest in this work.
Références
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
Clin Obes. 2019 Jun;9(3):e12309
pubmed: 30977293